Global Neurodegenerative Diseases Market Will Reach $11 billion in 2018 – Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinsons Disease Treatment will Boost Market Despite Patent Cliff

VN:F [1.9.22_1171]
Rating: 5.0/5 (2 votes cast)

Albany NY (March 21, 2013) (CULRAV.ORG) -

New Report Added in ResearchMoz Reports Database Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinsons Disease Treatment will Boost Market Despite Patent Cliff.

To Browse Full TOC, Tables & Figures visit: http://www.researchmoz.us/neurodegenerative-diseases-market-to-2018-new-product-entries-in-both-niche-and-broader-parkinsons-disease-treatment-will-boost-market-despite-patent-cliff-report.html

GBI Research, the leading business intelligence provider, has released its latest research “Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff”. A highly dynamic market Researchmozscenario is expected in Neurodegenerative diseases in the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer’s disease has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several major products. The market for Parkinson’s disease, on the other hand, is expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US, in spite of the fact that it will soon hit its own patent cliff. Additionally, the overall aging of populations the developed world is expected to increase the number of patients suffering from these diseases due to their relatively high prevalence in the elderly.
Scope
  • The current therapeutic environment in the treatment of AD, PD, HD and ALS across the top seven developed markets, including the US, Germany, France, the UK, Italy, Spain and Japan.
  • Market data on the geographical landscape and therapeutic landscape, including market size, annual cost of therapy, treatment usage patterns such as disease population and prescription populations.
  • Market forecasts for all four indications across the US, the top five countries in Europe (EU5) – Germany, France, the UK, Italy, and Spain- as well as Japan.
  • Key market drivers and barriers
  • The major deals that have taken place in the Neurodegenerative Diseases Market in recent years. Coverage includes Mergers and Acquisitions (M&As) as well as co-development and licensing agreements, which are segmented on the basis of geography and total value. A concomitant analysis of the licensing deal values for products by molecule types and is also provided.
Reasons to Buy
  • Understand the competitive environment for Neurodegenerative Diseases
  • Understand the clinical and commercial impact of major patent expiries in the neurodegenerative diseases markets
  • Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the neurodegenerative diseases market in the forecast period
  • Grasp the unmet need which exists in the neurodegenerative diseases Market
  • Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps

A highly dynamic market scenario is expected in neurodegenerative diseases over the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer’s disease (AD) has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several major products. However, the market for Parkinson’s disease is expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US even though it will soon hit its own patent cliff.

In spite of a number of high-profile clinical trial failures such as bapineuzumab and, to an extent, solanezumab for the treatment of AD, the overall pipeline for neurodegenerative diseases remains strong. It contains an estimated 678 pipeline products, most of which are being developed for the treatment of AD or Parkinson’s disease (PD). There are relatively few products in Phase III development, although Phases I and II are relatively populated with a variety of molecules. The largest stage of development in terms of the number of molecules is the preclinical stage, which accounts for 42% of the pipeline with 288 molecules identified at this stage.

GBI Research’s report “Neurodegenerative Diseases Market to 2018 – New Product Entries in Both Niche and Broader Parkinson’s Disease Treatment will Boost Market Despite Patent Cliff” provides analysis on the current therapeutic environment in the treatment of Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and Amyotrophic lateral sclerosis (ALS) across the top seven developed markets, including the US, Germany, France, the UK, Italy, Spain and Japan. The report provides market data on the geographical landscape and therapeutic landscape, including market size, annual cost of therapy, treatment usage patterns such as disease population and prescription populations. Important Mergers and Acquisitions (M&As) as well as co-development and licensing agreements are covered along with key market barriers and drivers.

####

Related Reports:

Neurodegenerative Diseases Pipeline Review, H1 2013

Global Markets Directs, ‘Neurodegenerative Diseases Pipeline Review, H1 2013′, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neurodegenerative Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurodegenerative Diseases. Neurodegenerative Diseases Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

Neurodegenerative Diseases – Pipeline Review, H2 2012

Global Markets Directs, ‘Neurodegenerative Diseases Pipeline Review, H2 2012′, provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Neurodegenerative Diseases, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neurodegenerative Diseases. Neurodegenerative Diseases Pipeline Review, Half Year is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team.

 

About Us

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

 

Contact

M/s Sheela

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-997-4948

Email: sales@researchmoz.us

http://www.researchmoz.us/

VN:F [1.9.22_1171]
Rating: 5.0/5 (2 votes cast)
VN:F [1.9.22_1171]
Rating: +2 (from 2 votes)
Global Neurodegenerative Diseases Market Will Reach $11 billion in 2018 - Neurodegenerative Diseases Market to 2018 - New Product Entries in Both Niche and Broader Parkinsons Disease Treatment will Boost Market Despite Patent Cliff, 5.0 out of 5 based on 2 ratings

Nish Kindle
Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning. ResearchMoz is the one stop online destination to find and buy market research reports.

No comments.

Leave a Reply

You must be logged in to post a comment.